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Abstract
Introduction: This study aims to evaluate EZSCAN detection in pilots and in the general population, and to determine the significance 
of EZSCAN detection in the identification of pilots’ health.
Material and methods: A total of 87 cases of non-diabetic Air Force pilots (pilot group) and 49 cases from the general population without 
diabetes were collected. These two groups of subjects underwent EZSCAN detection, as well as the detection of blood glucose, lipid, and 
uric acid levels.
Results: Subjects in the pilot group had the highest detection rate of no risk and the lowest detection rate of high risk, while the general 
population had the highest detection rate of high risk, followed by low risk. The difference in diabetic risk between these two groups was 
statistically significant (P < 0.01). Various indicators were compared according to different risk levels. In the no risk group, age, BMI, and 
the triglyceride of pilots were lower than in the general population, and the difference was statistically significant (P < 0.05). In high risk 
group, BMI and blood uric acid of pilots were lower than in the general population, and the difference was statistically significant (P < 0.05). 
Conclusions: BMI and blood uric acid are positively correlated with diabetic risk. The EZSCAN detection system can be used for assess-
ment of pilots’ diabetic risk and has certain significance in pilots’ health identification. (Endokrynol Pol 2018; 69 (3): 259–263)
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Streszczenie
Wstęp: Badanie miało na celu ocenę wykrywalności ryzyka wystąpienia cukrzycy techniką EZSCAN wśród pilotów i w populacji ogólnej 
oraz określenie znaczenia wykrywalności techniką EZSCAN w identyfikowaniu zdrowia pilotów.
Materiał i metody: W badaniu wzięło udział 87 niechorujących na cukrzycę pilotów sił powietrznych Air Force (grupa pilotażowa) oraz 
49 osób nieobciążonych cukrzycą z populacji ogólnej. W obu grupach przeprowadzono detekcję techniką EZSCAN, jak również zbadano 
stężenie glukozy we krwi, lipidów oraz kwasu moczowego.
Wyniki: U pacjentów z grupy pilotażowej wykazano najwyższy wskaźnik wykrywalności nieobciążenia ryzykiem i najniższy wskaźnik 
wykrywalności obciążenia wysokim ryzykiem, podczas gdy u pacjentów z populacji ogólnej wykazano najwyższy wskaźnik wykry-
walności obciążenia wysokim ryzykiem, po którym następowało niskie ryzyko. Różnica dotycząca ryzyka cukrzycy między obydwoma 
grupami była istotna statystycznie (p < 0,01). Porównano różne wskaźniki zgodnie z różnymi poziomami ryzyka. W grupie nieobciążonej 
ryzykiem, wiek, wskaźnik BMI i stężenie trójglicerydów pilotów były niższe niż w populacji ogólnej, a różnica była statystycznie istotna 
(p < 0,05). W grupie obciążonej wysokim ryzykiem, wskaźnik BMI i stężenie kwasu moczowego we krwi pilotów były niższe niż 
w populacji ogólnej, a różnica była statystycznie istotna (p < 0,05).
Wnioski: Wskaźnik BMI i stężenie kwasu moczowego we krwi są dodatnio skorelowane z ryzykiem wystąpienia cukrzycy. Metoda 
EZSCAN może być stosowana do oceny ryzyka wystąpienia cukrzycy u pilotów i ma pewne znaczenie w określaniu stanu zdrowia 
pilotów. (Endokrynol Pol 2018; 69 (3): 259–263)
Słowa kluczowe: EZSCAN, piloci, populacja kontrolna, ocena ryzyka zagrożenia cukrzycą
Introduction
The prevalence of diabetes continuously increases. 
According to the Chinese chronic disease surveillance 
and the research of the special investigation on diabetes 
project, there may be as many as 113.9 million adult 
diabetic patients, and 493.4 million pre-diabetic people 
in China [1]. Diabetes mellitus has become a major 
public health problem in China. Effective intervention 
in the pre-stage of diabetes can significantly reduce its 
conversion to diabetes. Therefore, detecting the high-
risk population and pre-stage population of diabetes in 
time and conducting effective management are keys to 
prevent the occurrence of diabetes [2]. EZSCAN (sweat 
gland ionic diabetic risk assessment system) is a new 
method of early diabetic risk assessment. It evaluates 
the risk of glucose metabolism by detecting sweat gland 
function via the reverse ion method. The test result is 
stable, and repeatability is high. Therefore, it has good 
prospective application in the screening of individuals 
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with high risk of diabetes and diabetic patients [3, 4]. 
Flight personnel are a special group, and studies of 
the risk of diabetes in pilots are rare. In this study, the 
EZSCAN system was used to explore the identification 
of diabetic risk and health in the general population 
and in the pilot population.
Material and methods
Material
Data on people who underwent health examinations 
in the Air Force General Hospital Health Examination 
Centre between January and July in 2014 were col-
lected. These subjects were divided into two groups: 
the pilot group (87 cases, of whom 82 were male and 
five were female) and the general non-diabetic group 
(general group; 49 cases, 45 cases were male and four 
were female). Exclusion criteria: subjects with diabetes, 
or with severe liver and kidney dysfunction, pregnant 
or lactating women, or patients with other major dis-
eases; patients with cardiac pacemakers or implanted 
defibrillators; patients who had defects in some parts 
of the body, which could not be detected by EZSCAN; 
subjects allergic to nickel or other electrodes.
Methods
Physical examination
Body height and weight of the subjects were measured 
using the Beijing Haiboerda height and weight meas-
urement instrument.
Laboratory examination
Venous blood was collected from all subjects after fast-
ing for at least 10 hours, the samples were sent to the 
hospital inspection centre, blood glucose and blood 
uric acid were detected using a Hitachi 7600 automatic 
biochemical analyser, and the blood lipids were simul-
taneously detected including total cholesterol, triglyc-
eride, high-density lipoprotein cholesterol (HDL-C), 
and low-density lipoprotein cholesterol.
EZSCAN diabetic risk assessment system
All subjects were detected by the EZSCAN diabetes 
and complication risk detection system, which was 
produced by Impeto Medical (France). EZSCAN has 
two kinds of work mode. The common mode is used for 
non-diabetic patients, in order to detect whether there 
is a risk of diabetes. The results are expressed with the 
comprehensive percentage of risk. The reading range 
is 0–100%. A range within 0–25% indicates no risk, 
a range within 25–50% indicates low risk, and a range 
within 50–100% indicates high risk; thus, a higher ratio 
represents a higher risk of diabetes [5].
The subjects do not need to fast for the detection, 
and high-intensity exercises should be prohibited two 
hours before the examination. The operator should 
clean the electrode plate, select the correct detection 
mode, and accurately input the subject’s informa-
tion according to the requirements. The electrodes 
should be placed at the areas of the subjects with an 
abundant sweat gland (two hands, two feet), and the 
subjects should stand quietly for 2–3 minutes. During 
the whole measurement process, the hands and feet 
of the subject should be located in the centre of the 
electrode plate, and the limbs should not be moved, to 
ensure the accuracy of the detection results. EZSCAN 
then calculates the electrical conductivity of the cor-
responding parts. The higher the value, the lower the 
risk of abnormal blood glucose. During the detection 
process, environmental and human disturbance factors 
should be avoided, in order to ensure the accuracy of 
the detection results.
Statistical methods SPSS 20.0 statistical software 
was used for data analysis. Continuous variables were 
expressed with c ± s, and categorical variables were 
expressed with case numbers (%). The comparison of 
continuous variables between these two groups was 
analysed using the Mann-Whitney method. The rates 
between these groups were compared by chi-square test. 
A P-value < 0.05 was considered statistically significant.
Results
Analysis of EZSCAN in the detection  
of diabetic risk
Among the 87 subjects in the pilot group, 29 subjects 
were at low risk and eight subjects were high risk. 
Among the 49 subjects in the general group, 16 subjects 
were at low risk and 18 subjects were at high risk. Sub-
jects in the pilot group had the highest detection rate of 
no risk and the lowest detection rate of high risk, while 
subjects in the general group had the highest detection 
rate of high risk, followed by low risk. The difference in 
diabetic risk between these two groups was statistically 
significant (X2 = 9.063, P < 0.01; Table I).
Table I. EZSCAN results comparison between pilots and 
general population [Number (%)]
Tabela I. Porównanie wyników badania za pomocą techniki 
ESZCAN wśród pilotów i populacji ogólnej (%)
Groups Pilots General 
population
c2 value P value
Non-risk 50 15
Risk 37 34 9.063 0.003
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Different diabetic risk-related biochemical  
indicators in the two groups of populations
Test results of biochemical indicators at different dia-
betic risk levels for both the pilot and general groups 
are shown in Table II and III. Subjects in the pilot group 
had the highest detection rate of no risk and the lowest 
detection rate of high risk, while subjects in the gen-
eral group had the highest detection rate of high risk, 
followed by low risk. The difference in diabetic risk 
between these two groups was statistically significant 
(P < 0.01). Different indicators were compared accord-
ing to diabetic risk levels. In the no-risk group, age, BMI, 
and triglyceride levels of pilots were lower than in the 
general population, and the difference was statistically 
significant (P < 0.05). In the high-risk group, BMI and 
blood uric acid levels of pilots were lower than in the 
general population, and the difference was statistically 
significant (P < 0.05).
Discussion
In order to detect and treat diabetes at an early stage, 
the American Diabetes Association (ADA) proposed 
a large-scale diabetic screening programme in the general 
population. This would provide intervention on dia-
betic risk factors, in order to provide the early diagnosis 
and treatment of diabetes, reduce complications, and 
decrease medical costs, thereby improving the quality 
of life of patients [6]. ADA guidelines recommend that 
populations > 45 years of age or with BMI ≥ 25 should 
undergo glucose metabolism screening [7]. However, 
survey results revealed that the majority of these popu-
lations did not undergo the corresponding detection. 
The main reason was that the commonly used screening 
method (OGTT) was invasive and patient compliance 
was poor [8]. At present, there are a lot of limitations in 
traditional diabetic detection methods. Diabetes could 
not be completely and accurately diagnosed solely 
through detection of fasting blood glucose, glycosylated 
haemoglobin, and blood glucose at two hours after 
a meal. By reverse iontophoresis counting, EZSCAN 
detection can evaluate whether the sweat gland func-
tion is abnormal through measuring sweat chloride 
concentrations and calculating the conductance of the 
corresponding parts. Fibrotic lesions appear in sym-
pathetic nerves (which dominate the sweat glands) in 
the early stage of diabetes and in the impaired glucose 
tolerance period. This causes the dysfunction of sweat 
glands, resulting in decreased sweat chloride ionic 
concentration and electrical conductivity. This abnor-
mality can be detected in diabetes even during the 
impaired glucose tolerance period [5, 9]. Mayaudon et 
al. [9] performed EZSCAN and blood glucose detection 
on 133 diabetic patients and 41 healthy subjects and 
found that the conductivity of the diabetic group was 
significantly lower than in the healthy control group. 
Table II. Basic data of pilots and general population [c ± s]
Tabela II. Dane dotyczące pilotów i populacji ogólnej [c ± s]
General population Pilots P value
Normal Low-risk High-risk Normal Low-risk High-risk Normal Low-risk High-risk
Number 15 16 18 50 29 8
Age 44.27 ± 5.56 50.75 ± 7.90 56.17 ± 11.56 37.16 ± 10.54 46.07 ± 8.47 49.50 ± 7.93 0.024 0.196 0.29
BMI 27.16 ± 3.05 25.41 ± 3.92 28.52 ± 2.84 25.00 ± 2.45 25.16 ± 3.19 25.26 ± 3.04 0.015 0.859 0.023
Table III. Biochemical test results of pilots and general population [c ± s]
Tabela III. Wyniki testów biochemicznych wśród pilotów i populacji ogólnej [c ± s]
General population Pilots P value
Normal Low-risk High-risk Normal Low-risk High-risk Normal Low-risk High-risk
GLU 5.28 ± 0.71 5.28 ± 1.51 5.39 ± 0.85 5.10 ± 0.42 5.06 ± 0.38 5.41 ± 0.99 0.421 0.359 0.867
TC 4.95 ± 1.03 5.14 ± 1.32 4.78 ± 0.86 4.55 ± 0.77 4.83 ± 0.71 4.38 ± 0.72 0.207 0.361 0.243
TG 3.50 ± 3.08 3.56 ± 5.44 2.25 ± 1.25 1.31 ± 0.78 2.17 ± 1.69 1.84 ± 1.15 0 0.158 0.505
HDL 1.10 ± 0.21 1.28 ± 0.41 1.10 ± 0.24 1.25 ± 0.31 1.19 ± 0.25 1.08 ± 0.20 0.05 0.602 0.934
LDL 2.94 ± 0.89 2.90 ± 1.02 2.89 ± 0.69 2.73 ± 0.64 2.98 ± 0.69 2.60 ± 0.54 0.511 0.749 0.331
BUA 397.67 ± 73.96 398.94 ± 132.16 406.39 ± 71.74 355.47 ± 69.41 356.10 ± 87.58 354.88 ± 28.59 0.101 0.538 0.024
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Furthermore, when the EZSCAN cut-off point was 50%, 
the diagnostic sensitivity and specificity of diabetes was 
75% and 100%, respectively. Ramachandran et al. [5] 
performed EZSCAN and glucose test on 212 subjects 
and found that when the EZSCAN cut-off point was 
50%, the diagnostic sensitivity and specificity of dia-
betes were 75% and 54%, respectively, and sensitivity 
was higher than in fasting plasma glucose (FPG, 29%). 
Sheng et al. [10] performed EZSCAN tests on 195 sub-
jects. They also found that conductivity in the diabetic 
group was significantly lower than in the non-diabetic 
group. When the EZSCAN cutoff point was 40%, the 
diagnostic sensitivity and specificity of diabetes were 
85% and 64%, respectively, and sensitivity was much 
higher than in FPG (44%) and HbA1c (56%). These 
results suggest that EZSCAN, as a new diabetic screen-
ing tool, is safe, noninvasive, and simple. Furthermore, 
test results are not easily hampered by the detection 
time, place, and gender of the subject. Moreover, it 
may have higher sensitivity and specificity, compared 
with traditional FPG and HbA1c detection [11, 12]. All 
these factors indicate that EZSCAN is an appropriate 
method that can be carried out for the early screening 
of diabetes in large-scale populations.
In this study we found that the risk of diabetes in the 
pilot population was lower than in the general popula-
tion. This is because pilots are a special group of people. 
They have undergone strict screening and evaluations, 
and their physical qualities are superior to those of 
the general population. Furthermore, they maintain a 
regular diet, perform regular exercise, and practice good 
living habits. In a disease spectrum study performed 
by Liu Hongjin et al. [13] on fighter pilots who were 
unqualified to fly, they found that there was an upward 
trend of hypertension and diabetes proportions in all 
the diseases that caused grounded. Wang Binru et al. 
[14] found that diabetes was one of the 10 diseases 
that caused aircrews to be grounded and affected an 
aviator’s service span. Through analysis of the disease 
spectrum of pilots’ annual physical examinations, 
Menke et al. [15] found that there was a high incidence 
of hyperlipidaemia, fatty liver, hyperuricaemia, and 
other endocrine, nutritional, and metabolism-related 
diseases. Therefore, it is necessary to monitor disease 
spectrum changes, and prevent and detect diabetes in 
the early stage. The results of this study revealed that 
blood uric acid levels in subjects in the high-risk group 
were higher than that in the low-risk group and normal 
group, which was consistent with previous research 
results [10, 16]. From the results of the study, we can 
observe that even in a high-risk population, the pilots’ 
BMI and blood uric acid values were lower than in the 
general population.
The age of subjects in the high-risk diabetic groups 
in these two kinds of populations were both higher than 
in the normal and low-risk groups. With the increase 
of age, the prevalence rate of diabetes exhibits a sharp 
upward trend. Hence, the greater the age, the higher 
the probability of suffering from diabetes becomes. This 
may be related to the atrophy of internal organs that 
starts during middle age and the decline of a variety of 
functions, excessive nutrition caused by poor lifestyle, 
decreased body sensitivity to insulin, and other factors. 
The trend of the prevalence rate of diabetes in the pilot 
population is becoming younger, which is related to the 
gradual reduction in physical activity and obesity. In 
this study, we found that the BMI index in the high-risk 
diabetes group for pilots and the general population 
was greater than in normal and low-risk groups. As BMI 
increased, the risk of abnormal glucose metabolism also 
increased. Furthermore, obesity is a very important risk 
factor for the occurrence and development of diabetes, 
which is consistent with the results of many related 
studies [17–20]. Therefore, controlling body weight 
has a positive effect on reducing the risk of abnormal 
glucose metabolism.
In China, the incidence rate of impaired glucose toler-
ance (IGT) is much higher than that of impaired fasting 
glucose (male: 11% vs. 3.2%; female: 10.9% vs. 2.2%) [21]. 
Therefore, it is very important to screen patients with IGT 
for the prevention and treatment of diabetes in China. 
Ramachandran et al. [5] performed EZSCAN and blood 
glucose examinations on 212 subjects and found that 
when the EZSCAN cut-off point was 50%, IGT detection 
sensitivity was 70%, which was significantly higher than 
in FPG (3%) when the cut-off was set at 6.1 mmol/L. Sub-
sequently, Ramachandran [22] followed-up 69 subjects 
with normal glucose metabolism for eight months and 
found that 23% of these subjects developed into IGT 
or diabetes. Survival curve analysis indicated that the 
risk of IGT incidence in patients with high risk (risk > 
65%) increased 6.19 times (OR: 6.19, 95% CI: 1.50–25.48) 
and the risk of IGT incidence in patients with medium 
risk (the risk was between 50% and 65%) increased by 
a factor of three (OR: 3.0, 95% CI: 0.98–9.19), compared 
to low-risk patients (EZSCAN risk percentage < 50%). 
In this study, it was also found that the sensitivity of 
EZSCAN in abnormal glucose tolerance detection was 
77%, which was higher than for FPG (14%) and HbA1c 
(66%). All of the above results suggest that EZSCAN has 
higher sensitivity for the detection of IGT, compared with 
traditional methods of blood glucose detection, and that 
this may have some predictive value for the occurrence 
of abnormal glucose metabolism. The EZSCAN diabetes 
risk score was significantly and positively correlated with 
the risk of type-2 diabetes.
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EZSCAN diabetes risk assessment system does not 
require fasting. It is noninvasive, can detect rapidly, 
is easy to perform, has high compliance, and is easy 
to popularise. Furthermore, it is especially suitable 
for diabetic risk screening when conducting physical 
examinations for a certain population and in carrying 
out health management activities in a population with 
diabetic risk. Although the diabetic risk in the pilot 
population was significantly lower than in the general 
population, in order to ensure the fighting capacity 
of the army, early screening should be performed on 
pilots. The detection of diabetic risk at an early stage 
would enable individuals to receive intervention at an 
early stage.
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